AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 137 filers reported holding AVIDITY BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $5,452,673 | -42.1% | 854,651 | +0.6% | 6.70% | -33.5% |
Q2 2023 | $9,422,630 | -27.8% | 849,651 | 0.0% | 10.08% | -26.8% |
Q1 2023 | $13,042,143 | -28.8% | 849,651 | +2.9% | 13.77% | -21.6% |
Q4 2022 | $18,317,246 | +34.3% | 825,473 | -1.2% | 17.56% | +1.9% |
Q3 2022 | $13,643,000 | +12.4% | 835,473 | 0.0% | 17.24% | +13.4% |
Q2 2022 | $12,139,000 | -26.2% | 835,473 | -6.1% | 15.20% | +2.2% |
Q1 2022 | $16,438,000 | -22.3% | 889,957 | +0.0% | 14.87% | -17.1% |
Q4 2021 | $21,144,000 | -5.4% | 889,537 | -2.0% | 17.94% | -8.8% |
Q3 2021 | $22,353,000 | -22.5% | 907,567 | -22.2% | 19.68% | +8.5% |
Q2 2021 | $28,830,000 | -4.6% | 1,166,747 | -15.8% | 18.14% | -1.6% |
Q1 2021 | $30,226,000 | -24.6% | 1,385,864 | -11.8% | 18.44% | -8.3% |
Q4 2020 | $40,096,000 | – | 1,571,160 | – | 20.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |